Haemonetics Profit Margin 2006-2019 | HAE

Current and historical gross margin, operating margin and net profit margin for Haemonetics (HAE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Haemonetics net profit margin as of March 31, 2019 is 5.69%.
Haemonetics Annual Profit Margins
Haemonetics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.325B $0.968B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.856B 28.70
Medtronic (MDT) Ireland $133.874B 19.12
Stryker (SYK) United States $76.669B 27.36
Boston Scientific (BSX) United States $59.033B 28.30
Baxter (BAX) United States $41.839B 26.37
EssilorLuxottica Societe Anonyme (ESLOY) France $29.060B 0.00
Coloplast (CLPBY) Denmark $25.618B 40.90
Zimmer Biomet Holdings (ZBH) United States $24.965B 16.04
Lonza Group Ag (LZAGY) Switzerland $24.947B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.274B 0.00
ResMed (RMD) United States $17.745B 33.90
Canopy Growth (CGC) Canada $12.161B 0.00
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Bio-Rad Laboratories (BIO) United States $9.308B 49.34
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.203B 524.78
Aurora Cannabis (ACB) Canada $7.109B 70.10
Perrigo (PRGO) Ireland $7.004B 11.84
Hill-Rom Holdings (HRC) United States $6.993B 21.20
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
ICU Medical (ICUI) United States $5.135B 30.64
GW Pharmaceuticals (GWPH) United Kingdom $5.057B 0.00
Neogen (NEOG) United States $3.349B 54.45
NuVasive (NUVA) United States $2.982B 24.36
Hutchison China MediTech (HCM) China $2.925B 0.00
Agios Pharmaceuticals (AGIO) United States $2.711B 0.00
National Vision Holdings (EYE) United States $2.420B 51.57
Quidel (QDEL) United States $2.309B 23.96
Cardiovascular Systems (CSII) United States $1.598B 917.80
Aphria (APHA) $1.579B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.41
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.187B 25.19
Lantheus Holdings (LNTH) United States $1.089B 28.93
NanoString Technologies (NSTG) United States $1.056B 0.00
PetIQ (PETQ) United States $0.994B 24.14
MacroGenics (MGNX) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.765B 21.47
Cerus (CERS) United States $0.758B 0.00
Quanterix (QTRX) United States $0.753B 0.00
Omeros (OMER) United States $0.750B 0.00
TG Therapeutics (TGTX) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.572B 27.71
Surmodics (SRDX) United States $0.543B 78.88
OraSure Technologies (OSUR) United States $0.531B 24.43
Meridian Bioscience (VIVO) United States $0.476B 14.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.404B 0.00
Vapotherm (VAPO) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.13
BioLife Solutions (BLFS) United States $0.304B 95.24
Zynex (ZYXI) United States $0.250B 25.67
Bovie Medical (APYX) United States $0.236B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.198B 4.20
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Female Health (VERU) United States $0.146B 0.00
Fonar (FONR) United States $0.139B 7.33
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.094B 20.65
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00